Terns Pharmaceuticals’ CEO Senthil Sundaram steps down for health reasons

Terns Phar­ma­ceu­ti­cals CEO Senthil Sun­daram has re­signed from his po­si­tion for health rea­sons.

Terns dis­closed in an SEC fil­ing in Jan­u­ary of last year that Sun­daram had re­ceived a can­cer di­ag­no­sis and would “un­der­go ag­gres­sive treat­ment, in­clud­ing chemother­a­py.” At the time, Sun­daram planned to main­tain his du­ties as CEO dur­ing treat­ment, but would “lim­it cer­tain busi­ness ac­tiv­i­ties, in­clud­ing trav­el.”

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters